Inventor profile of:

Hong Ding

City:

Gurnee, Illinois

Country:

United States

Published Applications:

46

Last publication date:

2025-01-16

Top Assignees for applications by Hong Ding

The entities that hold a legal rights for patent applications filed by inventor Ding Hong:

Recent patent applications by Ding Hong

Hong Ding from Gurnee, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-01-16
US20250019364A1
Chemistry; metallurgy

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#2 | 2024-02-08
US20240043404A1
Chemistry; metallurgy

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#3 | 2023-05-11
US20230143532A1
Chemistry; metallurgy

Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases

#4 | 2022-10-06
US20220315555A1
Chemistry; metallurgy

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#5 | 2021-07-22
US20210221789A1
Chemistry; metallurgy

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#6 | 2020-07-23
US20200231566A1
Chemistry; metallurgy

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#7 | 2019-04-25
US20190119247A1
Chemistry; metallurgy

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#8 | 2018-09-06
US20180251426A1
Chemistry; metallurgy

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#9 | 2017-06-08
US20170158666A1
Chemistry; metallurgy

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#10 | 2016-01-14
US20160009687A1
Chemistry; metallurgy

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

#11 | 2015-11-19
US20150329541A1
Chemistry; metallurgy

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#12 | 2015-07-02
US20150183775A1
Chemistry; metallurgy

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#13 | 2014-07-03
US20140187531A1
Chemistry; metallurgy

Apoptosis promoters

#14 | 2014-04-24
US20140113910A1
Chemistry; metallurgy

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#15 | 2014-04-17
US20140107119A1
Human necessities

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

#16 | 2014-04-03
US20140094471A1
Chemistry; metallurgy

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#17 | 2014-03-06
US20140066621A1
Chemistry; metallurgy

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#18 | 2014-02-27
US20140057890A1
Human necessities

BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

#19 | 2014-02-27
US20140057889A1
Human necessities

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

#20 | 2013-11-07
US20130296295A1
Human necessities

BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases

#21 | 2013-07-25
US20130190488A1
Chemistry; metallurgy

Apoptosis promoters

#22 | 2012-07-26
US20120190688A1
Chemistry; metallurgy

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#23 | 2011-10-27
US20110263599A1
Chemistry; metallurgy

1-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives

#24 | 2011-10-20
US20110256129A1
Chemistry; metallurgy

Apoptosis promoters

#25 | 2011-06-16
US20110144112A9
Chemistry; metallurgy

Apoptosis promoters

#26 | 2010-12-02
US20100305122A1
Chemistry; metallurgy

Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases

#27 | 2010-11-25
US20100298323A1
Chemistry; metallurgy

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#28 | 2010-11-25
US20100298321A1
Chemistry; metallurgy

BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

#29 | 2010-09-30
US20100249133A1
Chemistry; metallurgy

Apoptosis promoters

#30 | 2010-09-23
US20100240715A1
Chemistry; metallurgy

Apoptosis promoters

#31 | 2010-09-16
US20100234456A1
Chemistry; metallurgy

Biaryl carboxylic acid apoptosis promoters

#32 | 2010-07-22
US20100184750A1
Chemistry; metallurgy

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#33 | 2010-06-24
US20100160322A1
Chemistry; metallurgy

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#34 | 2010-06-17
US20100152183A1
Chemistry; metallurgy

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

#35 | 2010-01-28
US20100022773A1
Chemistry; metallurgy

Apoptosis promoters

#36 | 2009-05-28
US20090137585A1
Chemistry; metallurgy

N-acylsulfonamide apoptosis promoters

#37 | 2009-05-14
US20090124616A1
Chemistry; metallurgy

1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives

#38 | 2009-03-17
US10820097
-

N-acylsulfonamide apoptosis promoters

#39 | 2008-11-20
US20080287419A1
Chemistry; metallurgy

Apoptosis promoters

#40 | 2007-06-14
US20070135392A1
Chemistry; metallurgy

Apoptosis promoters

#41 | 2007-03-29
US20070072860A1
Chemistry; metallurgy

Apoptosis promoters

#42 | 2007-02-01
US20070027135A1
Chemistry; metallurgy

Apoptosis promoters

#43 | 2007-01-18
US20070015787A1
Chemistry; metallurgy

Apoptosis promoters

#44 | 2006-11-16
US20060258657A1
Chemistry; metallurgy

Apoptosis promoters

#45 | 2006-06-15
US20060128706A1
Chemistry; metallurgy

Apoptosis promoters

#46 | 2005-07-21
US20050159427A1
Chemistry; metallurgy

N-acylsulfonamide apoptosis promoters

InventorID:

356012 ⎘